Personal bio
Ryan Abbott, M.D., Esq., FCIArb has mediated and arbitrated disputes domestically and internationally with collectively tens of millions of dollars at stake. He has particular experience in the fields of intellectual property and health care, and offers unique expertise in such matters as biologics, pharmaceuticals, medical devices, medical and life sciences, computer technology and distributed ledger technology. Dr. Abbott divides his time between Los Angeles, California and London, England. Dr. Abbott has served as partner at a litigation firm and general counsel of biotechnology companies. In these capacities, he has substantial ADR experience as outside and inside counsel for both claimants and respondents. He has also worked as an expert for the European Commission, the United Kingdom Parliament, the World Intellectual Property Organization (WIPO), the World Health Organization (WHO) and the United Nations Development Programme (UNDP). Dr. Abbott is a licensed physician and patent attorney in the United States (California and New York) and a solicitor advocate in England and Wales. He is board certified by the American Board of Legal Medicine. In addition to serving as a JAMS neutral, he is a WIPO, IACT, and United Kingdom Intellectual Property Office (UKIPO) panelist, a CEDR-accredited mediator and a Fellow of the Chartered Institute of Arbitrators (FCIArb). He has a reputation for rigorous preparation, engagement and adaptability. Dr. Abbott is professor of law and health sciences at the University of Surrey School of Law and adjunct assistant professor of medicine at the David Geffen School of Medicine at UCLA. He is a graduate of the University of California San Diego School of Medicine and Yale Law School. Dr. Abbott lectures frequently on issues related to artificial intelligence, biotechnology, and information and communication technologies.